Kura Oncology, Inc. (KURA) NASDAQ

7.40

+0.055(+0.75%)

Updated at August 18 03:24PM

Currency In USD

Valuation

Market Cap750.46M
Enterprise Value542.59M
P/E Ratio-3.28
PEG Ratio0.43
Price/Sales Ratio7.71
Price/Book Ratio2.12
Enterprise/Revenue6.88
Enterprise/EBITDA-2.76

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-2.37
Operating Margin-2.64

Management Effectiveness

Return On Assets-0.29
Return On Equity-0.52

Income Statement

Revenue53.88M
Revenue/Share0.95
Gross Profit53.04M
EBITDA-169.5M
Net Income-173.98M
Diluted EPS-2.02

Balance Sheet

Total Cash630.73M
Total Cash/Share7.2
Total Debt12.96M
Total Debt/Equity0.04
Current Ratio6.16
Book Value Per Share3.49

Price History

52-Week Change-63.25
52-Week High21.57
52-Week Low5.41
Moving Average 50 Days6.23
Moving Average 200 Days8.15

Statistics

Average Volume1.42M
Shares Outstanding86.8M
% Held by Institutions89.04

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A